Document Detail

Decreased ovarian reserve relates to pre-eclampsia in IVF/ICSI pregnancies.
MedLine Citation:
PMID:  16951429     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Pre-eclampsia affects 2-10% of all pregnancies and is a major cause of maternal and fetal morbidity and mortality. As compared with the general population, IVF pregnancies are associated with a 2.7-fold risk of pre-eclampsia. An advanced age and associated subfertility in the IVF group reflects a general decrease in ovarian reserve, which itself has been linked to cardiovascular disease. We tested the hypothesis that decreased ovarian reserve is associated with pre-eclampsia as a vascular complication in IVF/ICSI pregnancies. METHODS: In this retrospective case-control study, 41 cases with a history of pre-eclampsia were compared to 82 matched controls without hypertension or (pre)eclampsia. All pregnancies were established after IVF or ICSI. Several indicators of ovarian reserve such as variables related to basal ovarian function and response to hyperstimulation were compared in both the groups by multivariate analysis. The condition of the neonates was evaluated as well. RESULTS: A higher amount of total administered FSH and FSH per day, together with a lower number of obtained oocytes during IVF treatment, were associated with an increased risk to pre-eclampsia in a subsequent pregnancy. The administered FSH per follicle and per obtained oocyte showed even stronger relationships, the latter having the best predictive value. Neonatal outcome was comparable between the groups. CONCLUSION: Diminished responsiveness of the ovaries to FSH stimulation in an IVF cycle, reflecting decreased ovarian reserve, is associated with an increased risk of developing pre-eclampsia in a subsequent pregnancy.
G H Woldringh; M H A Frunt; J A M Kremer; M E A Spaanderman
Related Documents :
20860419 - The relationship of preconception thyrotropin levels to requirements for increasing the...
19090499 - First-trimester maternal serum pregnancy-associated plasma protein-a and pre-eclampsia.
18958929 - Is there any link between severe pre-eclampsia and defined polymorphisms in leptin and ...
10766979 - Genetic effects on the liability of developing pre-eclampsia and gestational hypertension.
8518239 - Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy compl...
10189019 - Impaired antioxidant activity in women with pre-eclampsia.
18250639 - Successful pregnancy in a patient with landesman's group c autosomal dominant polycysti...
19463999 - Spontaneous rupture of subserous uterine veins during late pregnancy after in vitro fer...
8743159 - Placental nitric oxide metabolism.
Publication Detail:
Type:  Journal Article     Date:  2006-09-02
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  21     ISSN:  0268-1161     ISO Abbreviation:  Hum. Reprod.     Publication Date:  2006 Nov 
Date Detail:
Created Date:  2006-10-12     Completed Date:  2007-01-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  England    
Other Details:
Languages:  eng     Pagination:  2948-54     Citation Subset:  IM    
Department of Obstetrics and Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Case-Control Studies
Fertilization in Vitro*
Follicle Stimulating Hormone / blood
Maternal Age
Ovary / physiopathology*
Pre-Eclampsia / epidemiology*
Reference Values
Retrospective Studies
Risk Factors
Sperm Injections, Intracytoplasmic*
Reg. No./Substance:
9002-68-0/Follicle Stimulating Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  An ethical analysis of alternative methods to obtain pluripotent stem cells without destroying embry...
Next Document:  Structural basis for the mechanistic understanding of human CD38-controlled multiple catalysis.